Ipamorelin evidence check
Ipamorelin is claimed to help with injury recovery in humans.
Verdict
Limited Evidence with an evidence grade of C. Available evidence is limited or indirect. Public language should stay cautious until human clinical evidence is verified.
What this means
This grade applies only to the claim on this page, including the stated population and outcome. A supported claim in one context should not be stretched into a broader peptide promise.
What this does not mean
This page is not dosing guidance, a protocol, a recommendation to buy or use a product, or personal medical advice. High-risk claims need narrow wording, source links, and human review before publication.
Source trail
Evidence is listed by source type so you can see whether the claim rests on labeling, human studies, preclinical work, anecdotes, or vendor language.
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
ClinicalTrials.gov registry record for Ipamorelin / injury recovery. Status: COMPLETED. Phase: PHASE2. The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.
Open sourceSafety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
ClinicalTrials.gov registry record for Ipamorelin / injury recovery. Status: COMPLETED. Phase: PHASE2. Post-operative administration of ipamorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial small and/or large bowel resection.
Open sourcePharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.
Candidate PubMed evidence for Ipamorelin / injury recovery: Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Journal: Pharmaceutical research. This source supports evidence review and should not be treated as dosing guidance or personalized medical advice.
Open sourceProspective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients
Candidate PubMed evidence for Ipamorelin / injury recovery: Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Journal: International journal of colorectal disease. This source supports evidence review and should not be treated as dosing guidance or personalized medical advice.
Open sourceDetermination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin
Candidate PubMed evidence for Ipamorelin / injury recovery: Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. Journal: Drug testing and analysis. This source supports evidence review and should not be treated as dosing guidance or personalized medical advice.
Open sourceDisclosure
Disclosure: Some links may be affiliate links. Peptide Fact Checks may earn a commission if you use them. That does not affect evidence grades, verdicts, or vendor transparency notes.